Limited lists of drugs: lessons from abroad.
作者信息
Smith T
出版信息
Br Med J (Clin Res Ed). 1985 Feb 16;290(6467):532-4. doi: 10.1136/bmj.290.6467.532.
Abstract
摘要
相似文献
1
Limited lists of drugs: lessons from abroad.
Br Med J (Clin Res Ed). 1985 Feb 16;290(6467):532-4. doi: 10.1136/bmj.290.6467.532.
2
Rational prescribing and professional standards.
Med J Aust. 1994 May 2;160(9):564-7.
3
Doctors, drugs, and the DHSS.
Br Med J (Clin Res Ed). 1984 Dec 8;289(6458):1615-7. doi: 10.1136/bmj.289.6458.1615.
4
Administration of medicines. Part 1: The law and nursing.
Nurs Stand. 2003;18(2):47-53; quiz 54, 56. doi: 10.7748/ns2003.09.18.2.47.c3465.
5
[Off-label use and the 'explanation'].
Tijdschr Diergeneeskd. 2003 May 15;128(10):340-1.
6
Medicaid's new prescription drug legislation: prudent purchasing and drug use review.
Alaska Med. 1991 Oct-Dec;33(4):147-50.
7
Licence to save: a UK survey of anti-VEGF use for the eye in 2015.
Eye (Lond). 2016 Nov;30(11):1404-1406. doi: 10.1038/eye.2016.154. Epub 2016 Aug 12.
8
Limited lists of drugs: lessons from abroad.
Br Med J (Clin Res Ed). 1985 Mar 2;290(6469):710. doi: 10.1136/bmj.290.6469.710.
9
[Digitalis therapy in Germany. An example of indiscriminate drug prescription].
Dtsch Med Wochenschr. 1982 Dec 17;107(50):1935-8. doi: 10.1055/s-0029-1236827.
10
[Veterinary dispensary law and drug regulations].
Tierarztl Prax. 1982;10(1):1-10.
引用本文的文献
1
Impact of selective financing of drugs on pharmaceutical expenditure control in the province of Valladolid, Spain.
Pharmacoeconomics. 1996 Sep;10(3):269-80. doi: 10.2165/00019053-199610030-00008.
2
A UK national prescribing list?
Pharmacoeconomics. 1995 Jun;7(6):471-4. doi: 10.2165/00019053-199507060-00001.
3
A review of limited lists and formularies: are they cost-effective?
Pharmacoeconomics. 1992 Mar;1(3):191-202. doi: 10.2165/00019053-199201030-00006.
4
Prescription of drugs not listed in a clinic's pharmacopoeia: supervision by clinical pharmacologists.
Eur J Clin Pharmacol. 1991;40(6):561-4. doi: 10.1007/BF00279970.
5
Prescribing in Europe--forces for change.
BMJ. 1992 Jan 25;304(6821):239-42. doi: 10.1136/bmj.304.6821.239.
本文引用的文献
1
The regulatory control of non-steroidal anti-inflammatory agents.
Eur J Clin Pharmacol. 1981 Jan;19(1):3-10. doi: 10.1007/BF00558371.
2
Noninvestigational use of unapproved drugs--experience from the Scandinavian countries.
Med Care. 1981 Oct;19(10):1056-60. doi: 10.1097/00005650-198110000-00007.
3
IUDs: an appropriate contraceptive for many women.
Popul Rep B. 1982 Jul(4):101-35.
4
Contraceptive trends.
Br Med J (Clin Res Ed). 1984 Oct 13;289(6450):939-40. doi: 10.1136/bmj.289.6450.939.
5
Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.
Lancet. 1983 Oct 22;2(8356):930-4. doi: 10.1016/s0140-6736(83)90451-8.
6
Restrictions on NHS prescribing in Australia.
Br Med J. 1979 Jan 13;1(6156):99-100. doi: 10.1136/bmj.1.6156.99.
Zotero 插件